Skip to content

The effect of Zataria multiflora boiss capsule on postpartum pain

The effect of Zataria multiflora boiss capsule on postpartum pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016071128876N1
Enrollment
105
Registered
2017-01-03
Start date
2016-07-31
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postpartum afterpains. Postpartum care and examination

Interventions

Intervention 1: Intervention group: Capsule Zataria multiflora every 6 hours for 24 hours. Intervention 2: Control group: capsule of ibuprofen every 6 hours for 24 hours. Intervention 3: Control group
Treatment - Drugs
Intervention group: Capsule Zataria multiflora every 6 hours for 24 hours
Control group: capsule of ibuprofen every 6 hours for 24 hours
Control group: capsule of paracetamol every 6 hours for 24 hours

Sponsors

Vice chancellor for research,Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
17 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Iranian Mothers; speak Persian; having any communication problem; with at least literacy of writing and reading; live with his husband at the moment; the delivery must be vaginal and natural; the baby must be alive, singleton, and without malformations; gestational age must be between 37-42 weeks; it must be 2 hours after the mother's delivery; mother must complain about the labor and post-delivery pain; have moderate to severe post-delivery pain; be willing to take the painkiller; it must not be a high-risk pregnancy; delivery with no problems; the mother is able to take the drug orally; has the ability to breast-feed the baby; the baby must be able to suck the mother's breast; to relieve pain, mother must have taken no other medications at the time of hospitalization; she must be unaffected by medical conditions; she must not be taking long-term medications; she must have no history of cesarean section or abdominal surgery; not have the history of allergy to non-steroidal anti-inflammatory drugs and to acetaminophen; not have a history of sensitivity to herbal medicines and spices; she must not be addicted to drugs; the drugs or methods of analgesia must not be used during delivery. Exclusion criteria: Mother needs surgery and postpartum anesthesia received after the delivery; mother is suffering from serious complications after delivery; continuation of breastfeeding is not possible due to causes related to mother or baby; mother has any side effects associated with the studied drugs; mother, for any reason, is unwilling to continue the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postpartum afterpains. Timepoint: Before intervention,An hour after taking the capsules,Time to feel relief from pain. Method of measurement: Pain ruler.

Secondary

MeasureTime frame
Possible side effects of intervention. Timepoint: At the end of the intervention period. Method of measurement: At the end of the intervention period.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLadan Parsa

Shahid Beheshti University of Medical Sciences

ladan.parsa@sbmu.ac.ir+98 21 8865 5366

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026